Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-20

Clinical Trial Update: Liposomal Bupivacaine With Bupivacaine in Ankle Fracture Open Reduction Internal Fixation (ORIF) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating liposomal bupivacaine with standard bupivacaine for pain control in ankle fracture open reduction internal fixation has completed and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)
  • Exparel (liposomal bupivacaine)

Snippet

Sponsor: Jamaica Hospital Medical Center | Conditions: Ankle Fracture | Phase 3 | Status: COMPLETED | Results posted: 2017-10-20